电讯首科(03997.HK)斥400万元购股票挂钩定息票据
电讯首科(03997.HK)公布,全资附属於今日(11日)购入由瑞银集团发行的股票挂钩定息票据,票据息率12%,涉及400万元(未计及交易费用),将以内部资源拨付,年期为6个月,到期日为2021年11月29日。
挂钩股票分别为港交所(00388.HK)及腾讯(00700.HK),港交所发行价为443.6元,行使价401.2362元;腾讯控股发行价578元,行使价522.801元。
公司认为,定息票据具吸引票面利率,并能产生高於银行定期存款的潜在利息收益,於股权、行使价格及年期方面拥有相对灵活的选择,预期可提高潜在回报。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.